PRLD Prelude Therapeutics Incorporated - Common Stock

NASDAQ · Biotechnology · 在 SEC EDGAR 上查看 ↗
$4.33
价格 · 五月 20, 2026
截至...的财报数据 五月 12, 2026
52周区间
$1–$6
75% of range
分析师评级
BUY
9 analysts
目标价
$7
+59% upside
P/E (TTM)
-2.2
ROE
-137.7%
净利润率
-819.6%

PRLD 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围

价格
$4.33
市值
—
P/E (TTM)
-2.2
每股收益 (TTM)
$-1.29
营收 (TTM)
$12M
股息收益率
—
ROE
-137.7%
负债/权益
—
52周区间
$1 – $6

PRLD 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图

10年表现 收入、净利润、利润率和每股收益趋势

营收与净利润 $12M
2-point trend, +73.4%
2024-12-31 → 2025-12-31
EPS $-1.29
5-point trend, +46.9%
2021-12-31 → 2025-12-31
自由现金流 $-56M
6-point trend, -20.5%
2020-12-31 → 2025-12-31
利润率 -819.6%

估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？

指标
5年趋势
PRLD
同行中位数
P/E (TTM)
5-point trend, +56.1%
-2.2
9.4

盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)

指标
5年趋势
PRLD
同行中位数
Operating Margin (营业利润率)
2-point trend, +56.8%
-861.3%
—
Net Profit Margin (净利润率)
2-point trend, +54.9%
-819.6%
-205.9%
ROA
5-point trend, -48.7%
-62.8%
-30.4%
ROE
5-point trend, -268.2%
-137.7%
-54.4%

财务健康 债务、流动性、偿付能力 — 资产负债表强度

指标
5年趋势
PRLD
同行中位数
Current Ratio (流动比率)
5-point trend, -87.0%
2.0
3.8
Quick Ratio (速动比率)
5-point trend, -87.2%
1.9
—

成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)

指标
5年趋势
PRLD
同行中位数
Revenue YoY (营收同比增长)
2-point trend, +73.4%
73.4%
—

每股指标 每股收益 (EPS)、每股净资产、每股现金流、每股股息

指标
5年趋势
PRLD
同行中位数
EPS (Diluted) (EPS (稀释))
5-point trend, +46.9%
$-1.29
—

资本效率 资产周转率、库存周转率、应收账款周转率

指标
5年趋势
PRLD
同行中位数

PRLD 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间

买入 9 位分析师
  • 强烈买入 3 33.3%
  • 买入 5 55.6%
  • 持有 1 11.1%
  • 卖出 0 0.0%
  • 强烈卖出 0 0.0%

12个月价格目标

4 位分析师 · 2026-05-14
中位数目标 $7.00 +61.7%
平均目标 $6.88 +58.8%

收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期

平均惊喜
0.03%
期间 EPS Actual EPS 预期 惊喜
2026年3月31日 $-0.13 $-0.25 0.12%
2025年12月31日 $-0.20 $-0.03 -0.17%
2025年9月30日 $-0.26 $-0.37 0.11%
2025年6月30日 $-0.41 $-0.45 0.04%
2025年3月31日 $-0.42 $-0.48 0.06%

同行比较 关键指标与行业同行对比

股票代码 市值 P/E 营收同比增长 净利润率 ROE 毛利率
PRLD — -2.2 73.4% -819.6% -137.7% —
ELDN $114M -2.9 — — -69.4% —
RGNX $733M -3.8 104.5% -113.8% -122.5% —
NVCT $194M -5.7 — — -149.9% —
SABS — — — — — —
MGNX $102M -1.4 -0.31% -49.9% -87.0% —
ALXO $61M -0.6 — — -225.0% —
AKBA $427M -80.5 47.5% -2.3% -17.3% —
TARA $286M -4.0 — — -33.7% —
ZNTL $93M -0.7 — — -49.5% —

完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表

损益表 13
PRLD 的年度损益表数据
指标 趋势 20252024
Revenue 2-point trend, +73.4% $12M $7M
R&D Expense 2-point trend, -20.1% $94M $118M
SG&A Expense 2-point trend, -22.0% $22M $29M
Operating Expenses 2-point trend, -20.5% $117M $147M
Operating Income 2-point trend, +25.2% $-105M $-140M
Other Non-op 2-point trend, -59.6% $5M $13M
Income Tax Flat — no change across 2 periods $0 $0
Net Income 2-point trend, +21.8% $-99M $-127M
EPS (Basic) 2-point trend, +23.2% $-1.29 $-1.68
EPS (Diluted) 2-point trend, +23.2% $-1.29 $-1.68
Shares (Basic) 2-point trend, +1.5% 76,956,194 75,805,840
Shares (Diluted) 2-point trend, +1.5% 76,956,194 75,805,840
EBITDA 2-point trend, +25.4% $-103M $-138M
资产负债表 18
PRLD 的年度资产负债表数据
指标 趋势 20252024
Cash & Equivalents 2-point trend, +182.6% $35M $12M
Short-term Investments 2-point trend, -43.9% $68M $121M
Prepaid Expense 2-point trend, +8.6% $2M $2M
Current Assets 2-point trend, -22.2% $106M $136M
PP&E (Net) 2-point trend, -24.4% $5M $7M
PP&E (Gross) 2-point trend, +0.1% $12M $12M
Accum. Depreciation 2-point trend, +31.8% $7M $5M
Total Assets 2-point trend, -19.5% $141M $176M
Accounts Payable 2-point trend, -48.5% $4M $8M
Accrued Liabilities 2-point trend, -17.6% $13M $15M
Current Liabilities 2-point trend, +106.7% $53M $26M
Capital Leases 2-point trend, -1.8% $15M $15M
Other Non-current Liabilities 2-point trend, -8.1% $3M $3M
Total Liabilities 2-point trend, +65.0% $73M $44M
Retained Earnings 2-point trend, -17.1% $-683M $-584M
AOCI 2-point trend, -77.1% $8.0K $35.0K
Stockholders' Equity 2-point trend, -47.8% $69M $131M
Liabilities + Equity 2-point trend, -19.5% $141M $176M
现金流 11
PRLD 的年度现金流数据
指标 趋势 20252024
D&A 2-point trend, -3.4% $2M $2M
Stock-based Comp 2-point trend, -44.2% $12M $21M
Restructuring $1M ·
Other Non-cash 2-point trend, +2431.8% $30M $1M
Operating Cash Flow 2-point trend, +45.3% $-56M $-103M
CapEx 2-point trend, -91.2% $67.0K $764.0K
Investing Cash Flow 2-point trend, -40.7% $53M $90M
Financing Cash Flow 2-point trend, +20780.0% $25M $-120.0K
Net Change in Cash 2-point trend, +271.4% $22M $-13M
Taxes Paid Flat — no change across 2 periods $0 $0
Free Cash Flow 2-point trend, +45.6% $-56M $-104M
盈利能力 5
PRLD 的年度盈利能力数据
指标 趋势 20252024
Operating Margin 2-point trend, +56.8% -861.3% -1995.9%
Net Margin 2-point trend, +54.9% -819.6% -1816.8%
EBITDA Margin 2-point trend, +57.0% -847.2% -1970.6%
ROA 2-point trend, -11.9% -62.8% -56.1%
ROE 2-point trend, -55.9% -137.7% -88.3%
流动性与偿付能力 2
PRLD 的年度流动性与偿付能力数据
指标 趋势 20252024
Current Ratio 2-point trend, -62.4% 2.0 5.3
Quick Ratio 2-point trend, -62.6% 1.9 5.2
效率 1
PRLD 的年度效率数据
指标 趋势 20252024
Asset Turnover 2-point trend, +147.9% 0.1 0.0
每股 3
PRLD 的年度每股数据
指标 趋势 20252024
Revenue / Share 2-point trend, +71.0% $0.16 $0.09
Cash Flow / Share 2-point trend, +46.1% $-0.73 $-1.36
EPS (TTM) 2-point trend, +23.2% $-1.29 $-1.68
增长率 1
PRLD 的年度增长率数据
指标 趋势 20252024
Revenue YoY 73.4% ·
估值 (TTM) 4
PRLD 的年度估值 (TTM)数据
指标 趋势 20252024
Revenue TTM 2-point trend, +73.4% $12M $7M
Net Income TTM 2-point trend, +21.8% $-99M $-127M
P/E 2-point trend, -196.2% -2.2 -0.8
Earnings Yield 2-point trend, +66.2% -44.5% -131.8%

财务报表 损益表、资产负债表、现金流量表 — 年度，近5年

损益表
2025-12-312024-12-312023-12-312022-12-312021-12-31
收入 $12M$7M———
营业利润率 % -861.3%-1995.9%———
净收入 $-99M$-127M$-122M$-115M$-112M
稀释后每股收益 (EPS) $-1.29$-1.68$-2.02$-2.44$-2.43
资产负债表
2025-12-312024-12-312023-12-312022-12-312021-12-31
流动比率 2.05.310.89.415.4
速动比率 1.95.210.79.315.2
现金流
2025-12-312024-12-312023-12-312022-12-312021-12-31
自由现金流 $-56M$-104M$-111M$-87M$-86M

最新新闻 提及该公司的近期头条新闻

我的指标 您的个人关注列表 — 来自完整基本面的选定行

📊

选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。

您的选择已保存，并会跟随您浏览所有股票。